Aster Capital Management DIFC Ltd bought a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,792 shares of the company's stock, valued at approximately $685,000.
Several other institutional investors also recently made changes to their positions in the stock. Cyrus J. Lawrence LLC bought a new position in Cardinal Health during the 4th quarter worth $26,000. Promus Capital LLC acquired a new position in shares of Cardinal Health during the fourth quarter valued at $30,000. Lee Danner & Bass Inc. bought a new position in shares of Cardinal Health during the fourth quarter worth about $35,000. Kentucky Trust Co acquired a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $41,000. Finally, HHM Wealth Advisors LLC boosted its position in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock worth $47,000 after buying an additional 144 shares during the period. 87.17% of the stock is owned by institutional investors.
Cardinal Health Stock Performance
Shares of NYSE:CAH traded up $2.03 during midday trading on Friday, reaching $130.91. The company had a trading volume of 636,790 shares, compared to its average volume of 2,169,955. The company has a fifty day simple moving average of $129.20 and a two-hundred day simple moving average of $122.23. The firm has a market cap of $31.62 billion, a price-to-earnings ratio of 24.42, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.54%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is currently 37.69%.
Analysts Set New Price Targets
Several analysts recently commented on CAH shares. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Mizuho increased their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Morgan Stanley boosted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Bank of America increased their price objective on shares of Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a report on Friday. Finally, Citigroup boosted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a report on Friday, January 10th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $140.86.
Check Out Our Latest Research Report on CAH
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.